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The type 5 phosphodiesterase inhibitor vardenafil (VAR)
reduces myocardial infarct size following ischemia/ reper-
fusion injury when applied prior to ischemia or at reper-
fusion in models of in situ hearts. Little is known about
the underlying protective signaling. Here, we test whether
VAR is protective in a cell model of calcium stress as well
as in isolated rat hearts. HL-1 cardiomyocytes were loaded
with tetramethylrhodamine ethyl ester (TMRE, 100 nM)
which causes cells to fluoresce proportional to their mito-
chondrial membrane potential (Ψm). A reduction of flu-
orescence serves as an indicator of collapse of Ψm, and,
presumably to permeability transition pore (mPTP) for-
mation. Cells were subjected to the calcium ionophore
calcimycin (CAL) (100 µM) which causes mPTP forma-
tion due to calcium overload. Fluorescence intensity was
measured after 80 minutes of calcium stress with FACS
technique. Treatment with CAL reduced the mean cell flu-
orescence (903 ± 28 arbitrary units (a.u.), vs. 548 ± 29 a.u.
in untreated cells, p < 0.001) while VAR (1 nM) could pro-
tect the cells (698 ± 40 a.u., p < 0.001). This protection
could be blocked by either the guanylyl cyclase (GC)
inhibitor ODQ (20 µM) (519 ± 41 a.u.) or the protein
kinase G blocker KT5823 (1 µM) (513 ± 22 a.u.), while
inhibition of NO-synthase with L-NAME had no effect. To
further support the results, isolated rat hearts were sub-
jected to 30 min regional ischemia followed by 120 min
reperfusion. As expected, VAR (10 nM) at 5 min prior to
reperfusion reduced infarct size as percentage of the
ischemic zone from 46.6 ± 2.1% in control hearts to 26.2
± 2.7% (p < 0.001). This protective effect could be blocked
with co-administration of ODQ (43.9 ± 2.2%), while L-
NAME was not effective, confirming a role for GC but not
for NOS in VAR's protection. Taken together, these results
further support the hypothesis that PDE-5 inhibitors
induce protective effects in the ischemic heart in addition
to their well known clinical effects in the treatment of
erectile dysfunction in men.
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